JeffreyGroup supports AstraZeneca with internal, external, and digital communications to reinforce the global biopharmaceutical company’s reputation as a pioneer of science and patient-led innovation in Latin America. Through strategic public relations, thought leadership initiatives, and partnerships with academic institutions and media outlets, JeffreyGroup aims to boost AstraZeneca’s brand recognition and visibility, building a new narrative beyond the COVID-10 vaccine, while positioning the company as a driver of economic growth in the region and a key player within the sustainability space.